NCT06521567 2025-11-12
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
GlaxoSmithKline
Phase 1/2 Active not recruiting
GlaxoSmithKline
Immunitas Therapeutics
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Ann & Robert H Lurie Children's Hospital of Chicago